Clinical Study
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies
Figure 4
Anti-HLA ab and pAMR. Distribution of pAMR grades in patients with and without pretransplant HLA ab.